Qube Research & Technologies (QRT)
MYOK

Qube Research & Technologies (QRT)’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,960
Closed -$289K – 1872
2019
Q4 		$289K Buy
+3,960
New +$240K 0.01% 1238

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MYOK Position: Q1 2020 in Review

Qube Research & Technologies (QRT) sold out of MyoKardia, Inc. Common Stock (MYOK) in Q1 2020, closing a stake of 3,960 shares — an estimated $289K sold.

Qube Research & Technologies (QRT) first reported a position in MYOK in Q4 2019 and held it in 1 quarter. The position peaked at $289K in Q4 2019. 194 funds tracked by Wall St. Rank hold MYOK as of Q1 2020.

  • Qube Research & Technologies (QRT) reported no remaining MyoKardia, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3,960 MyoKardia, Inc. Common Stock shares in Q1 2020, an estimated $289K.
  • Qube Research & Technologies (QRT) first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s MyoKardia, Inc. Common Stock position peaked at $289K in Q4 2019.
  • 194 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2020, filed 15 May 2020.